Loading chat...
WA HB2113
Bill
Status
3/9/2026
Primary Sponsor
Andrew Engell
Click for details
AI Summary
-
Amends supervision requirements for diagnostic radiologic technologists, therapeutic radiologic technologists, and magnetic resonance imaging technologists performing parenteral procedures related to radiologic technology
-
Allows intravenous contrast procedures to be performed under "virtual direct supervision" via real-time interactive audio and video technology (excluding audio-only) by a licensed physician
-
Expands who can directly supervise intravenous contrast procedures to include physicians, advanced practice registered nurses, and physician assistants
-
Requires clinical staff with training to respond to adverse events be present on-site at the facility before technologists may administer intravenous contrast agents
-
Removes previous language requiring direct physician supervision for all parenteral procedures, creating a more flexible supervision framework
Legislative Description
Concerning the supervision of diagnostic radiologic technologists, therapeutic radiologic technologists, and magnetic resonance imaging technologists.
Last Action
Effective date 6/11/2026.
3/9/2026